EORTC QLQ CR-29 evaluation in 500 patients with colorectal cancer.

Author:

Abstract
429 Background: Colorectal cancer represents the 4th most frequent cancer in the world and is the 2nd leading cause of death due to cancer. This disease has a negative impact in the Quality of Life (QoL), due to its associated symptoms and due to the used treatments (surgery, chemotherapy and radiotherapy). Therefore it is fundamental to evaluate and assure a good quality of life of this patients and define the best QoL instrument in Colorectal cancer. Methods: Type of study: Transversal study The main objective was: validate for Portuguese population CR29 instrument. The QLQ-CR29 was administered with the QLQ-C30, core questionnaire, to 500 portuguese patients. Questionnaire scaling and reliability were established and clinical and psychometric validity examined. Patient acceptability and understanding were assessed with a debriefing questionnaire. Results: 57.4% (287) are male with a median of age of 66,67 years (Min.: 34 e Máx.: 88), 55.2% had rectal cancer (35.7% were Stage III disease at diagnosis. 46.4% had adjuvant and 27.4% had neoadjuvant treatment. The mean value of the QLQ-C30 Global Health Status was 58,75. The CR29 Multi-trait scaling analyses and face validity refined the module to four scales assessing urinary frequency, faecal seepage, stool consistency and body image and single items assessing other common problems following treatment for colorectal cancer identifying different groups of patients. High scores of cognitive and social functioning scales (QLQ C30), Subscale Corporal Image and the functional item Female Sexual function (QLQ-CR29) were related with good QoL. Low scores of Emotional Functioning subscales (QLQ C30) and Anxiety (QLQ-CR29), were related with poor QoL. A multivariable analysis reveals that sex, scholarship, marital status, distance between home and hospital and disease recurrence affect significantly the global health score. Conclusions: QLQ-CR29 Scale did not correlate with QLQ-C30 scales, demonstrating construct validity and it is a good instruments to identify a poor QoL in patients with colorectal cancer.